| MolName | 3,6-diamino-N-[[(8E)-15-amino-11-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide |
| MolecularFormula | C25H44N14O8 |
| Smiles | NCCCC(CC(NCC(C(N/C(/C(NC(C1NC(N)=NCC1)C(NCC(C(NC1CO)=O)N)=O)=O)=C/NC(N)=O)=O)NC1=O)=O)N |
| InChI | InChI=1S/C25H44N14O8/c26-4-1-2-11(27)6-17(41)32-8-14-20(43)35-15(9-34-25(30)47)21(44)39-18(13-3-5-31-24(29)38-13)23(46)33-7-12(28)19(42)37-16(10-40)22(45)36-14/h9,11-14,16,18,40H,1-8,10,26-28H2,(H,32,41)(H,33,46)(H,35,43)(H,36,45)(H,37,42)(H,39,44)(H3,29, |
| InChIK | JNIIDKODPGHQSS-UHFFFAOYSA-N |
| TotalMolweight | 668.714 |
| Molweight | 668.714 |
| MonoisotopicMass | 668.346656 |
| CLogP | -9.1605 |
| CLogS | -1.574 |
| H Acceptors | 22 |
| H Donors | 14 |
| TotalSurfaceArea | 497.9 |
| Relative PSA | 0.57024 |
| PolarSurfaceArea | 378.42 |
| Druglikeness | 4.4994 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.42553 |
| Fragments | 1 |
| Non HAtoms | 47 |
| NonCHAtoms | 22 |
| Electronegative Atoms | 22 |
| StereoCenters | 6 |
| Rotatable Bond | 10 |
| Rings Closures | 2 |
| Small Rings | 1 |
| Sp3Atoms | 19 |
| Amides | 8 |
| Amines | 3 |
| AlkylAmines | 3 |
| BasicNitrogens | 4 |
| StereoCon | unknown chirality |
Click to Load Molecule:
1 - 3,6-diamino-N-[[(8E)-15-amino-11-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide | 2 - 3,6-diamino-N-[[(8E)-15-amino-11-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide